AgeneBio

AgeneBio

AgeneBio

AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.
Founded
2008
Raised
$4.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$400,000
Debt financing - 2015
$4,113,127
Venture capital - 2014
Team Size
2
Employees
Technical.ly Baltimore

AgeneBio receives $3.4M for development of Alzheimer's treatment